Gm-csf for use in the prevention of spontaneous abortion and embryo implantation failure
OwnerFabio Scarpellini, Marco Sbraciainventors
Life of this patent
Estimating the term…
Abstract
The invention relates to GM-CSF for use in a method for the prevention of spontaneous abortion in a subject suffering from recurrent miscarriage, comprising administering to said subject an effective amount of GM-CSF as sole active substance, wherein said method also prevents or reduces the likelihood of embryo implantation failure in the subject undergoing an assisted reproduction procedure.
Claims9
Method of preventing spontaneous abortion in a subject suffering from recurrent miscarriage, said method comprising administering to said subject an effective amount of GM-CSF, as the sole active substance, wherein said method also prevents or reduces the likelihood of implantation failure in said subject, when undergoing an assisted reproduction procedure.
Dependencies are inferred from the claim text.